NCT02227667 2021-06-18
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
5 trialsNCT03427268 2021-05-24
Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment
PharmaMar
Phase 2 Completed
NCT00637091 2021-01-22
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
Asan Medical Center
Phase 2 Completed
NCT00309179 2017-09-14
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
Eisai Inc.
Phase 2 Completed
NCT00286000 2007-12-28
High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study
University Hospital, Ghent
Phase 2 Completed